Showing results (521-530 of 570) with videos related to

Sort By:
Pageof 57
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein CHanna Willander, Glareh Askarieh, Michael Landreh, et al.
Circulation|January 26, 1999
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries StudyC Y Tung, C B Granger, M A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
The New England Journal of Medicine|November 23, 2007
Lenalidomide plus dexamethasone for relapsed or refractory multiple myelomaMeletios Dimopoulos, Andrew Spencer, Michael Attal, et al.
The New England Journal of Medicine|November 23, 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North AmericaDonna M Weber, Christine Chen, Ruben Niesvizky, et al.
Analytical Chemistry|July 2, 2004
Improving reproducibility and sensitivity in identifying human proteins by shotgun proteomicsKatheryn A Resing, Karen Meyer-Arendt, Alex M Mendoza, et al.
Prosthetics and Orthotics International|December 21, 2021
Toward improving residual limb climate within prostheses for persons with lower limb loss: a technical noteAshley D Knight, Brad D Hendershot, Todd J Sleeman, et al.
The Journal of Biological Chemistry|December 5, 2020
Multivalent lipid targeting by the calcium-independent C2A domain of synaptotagmin-like protein 4/granuphilinAml A Alnaas, Abena Watson-Siriboe, Sherleen Tran, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Molecular Microbiology|January 22, 2005
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesinJulie Bouckaert, Jenny Berglund, Mark Schembri, et al.
Pageof 57